Back to HHLR Advisors, Ltd. HHLR Advisors, Ltd.

ONCONC

Showing 8 of 31 quarters

Position history for HHLR Advisors, Ltd.HHLR Advisors, Ltd.'s holdings in BeOne Medicines Ltd.

No. HHLR Advisors exited its ONC (BeOne Medicines) position in Q2 2026. Its Q1 2026 13F listed 1,034,306 shares worth $307.2M. HHLR Advisors already held ONC in its Q4 2018 13F, the earliest on record, and held it in 30 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.2B

Total Shares Change

-5.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$284.97
0
2026-Q1
Unchanged
1M
0.0%
$307.2M18.4%$296.97
0
2025-Q4
Unchanged
1M
0.0%
$314.2M10.1%$303.81
0
2025-Q3
Unchanged
1M
0.0%
$352.4M8.6%$340.70
0
2025-Q2
Unchanged
1M
0.0%
$250.4M8.1%$242.07
0
2025-Q1
Decreased
1M
-72.8%
$281.5M8.0%$272.17
0
2024-Q4
Decreased
3.8M
-26.5%
$702.7M24.3%$184.71
0
2024-Q3
Unchanged
5.2M
0.0%
$1.2B25.5%$224.51
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used